Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

The scrubbing of clinical trial-related pages is notable because of how it could affect the ways researchers both inside and ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

New Rule Seeks to Expand Medicare and Medicaid Coverage of Weight Loss Drugs. The Biden Administration has proposed a new ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...